New Agreement Between Medpod and Uber Health Enables Health Care Professionals to Deliver Telediagnostic Examinations in Non-Traditional Care Settings
MELVILLE, N.Y.–(BUSINESS WIRE)–Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), and exclusive distributor of Medpod Inc., today announced the availability of Medpod® MobileDoc® 2, integrated with Uber Health. The medical microcart, which is packed into a portable, carry-on sized case, will enable health care practitioners to conduct remote telediagnostic examinations for patients in non-traditional care settings, such as homes, offices, schools, ambulances and senior care facilities.
Further enhancing patients’ ability to receive convenient care, Medpod and Uber Health have entered into an agreement, with Uber Health providing Medpod access to Uber Health’s browser-based online dashboard, allowing for the integration of the Uber Health service directly into Medpod’s end-to-end telediagnostics platform. As a result, practitioners with a MobileDoc or MobileDoc 2 can dispatch an Uber driver partner to a patient’s location, or arrange for a patient to be driven by Uber Health to a clinical care setting.
The patent-pending MobileDoc 2 is Medpod’s second generation mobile microcart featuring professional-grade medical devices and instruments — such as dermatoscopes (examines skin lesions) and electrocardiograms (detects heart attacks and heart rhythm problems) — that can mobilize and enhance access to care. With this new solution, health care professionals can transform any environment into a clinical care setting, ultimately expanding provider reach with house calls and hospital-at-home settings. Additionally, the MobileDoc 2 can deliver:
- Remote consultations, similar to a face-to-face visit, with easy rollout of patient-centric exams, via professional diagnostic tools to capture patients’ temperatures, peripheral capillary oxygen saturation (SpO2), blood pressure, height, weight, and body mass index (BMI).
- Additional opportunities to create new pathways to help reduce costs for both providers and patients;
- Improved convenience and patient outcomes;
- Flexible and customizable mobile medical infrastructure with optimized mobile cellular service and Wi-Fi as well as live video, audio, clinical, and lab data streaming;
- Remote telediagnostic device control; and
- Access through a web browser with no software installation required.
“Henry Schein Medical is eager to bring this expanded Medpod offering to our customers in multiple market segments, helping transform their practices and improve relationships with patients looking for convenient access to health care,” said Brad Connett, President, U.S. Medical Group, Henry Schein. “Together with Medpod and Uber Health, we look forward to expanding off-site point-of-care options our customers can rely on to meet their patients’ portable needs.”
To ensure the success of this partnership, a pilot program will be rolled out to customers based on Uber Health resources, capacity, and build out for deployment.
“Our new partnership with Uber Health, and launch of Medpod MobileDoc 2, will help break down barriers that had previously required diagnostic exams to take place in traditional care settings,” said Jack Tawil, Chairman and Chief Executive Officer, Medpod Inc. “With the MobileDoc 2’s ability to take the physician office environment into patients’ homes and other non-traditional settings, we can create new convenient care delivery options and access points for patients.”
“Uber Health is excited to partner in this effort to drive the new house call, and deliver personalized, concierge medicine, changing the traditional health care delivery model,” said Dan Trigub, Head of Uber Health.
For more information, call 1.800.P.SCHEIN or visit www.HenrySchein.com/Medpod.
About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 19,000 Team Schein Members worldwide, the Company’s network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.
A FORTUNE 500 Company and a member of the S&P 500® and the Nasdaq 100® indexes, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 31 countries. The Company’s sales from continuing operations reached $9.4 billion in 2018, and have grown at a compound annual rate of approximately 13 percent since Henry Schein became a public company in 1995.